Literature DB >> 21077798

Comparison of amyloid fibril formation by two closely related immunoglobulin light chain variable domains.

Douglas J Martin1, Marina Ramirez-Alvarado.   

Abstract

Light chain amyloidosis (AL amyloidosis) is a haematological disorder in which a clonal population of B cells expands and secretes enormous amounts of the immunoglobulin light chain protein. These light chains misfold and aggregate into amyloid fibrils, leading to organ dysfunction and death. We have studied the in vitro fibril formation kinetics of two patient-derived immunoglobulin light chain variable domain proteins, designated AL-09 and AL-103, in response to changes in solution conditions. Both proteins are members of the κI O18:O8 germline and therefore are highly similar in sequence, but they presented with different clinical phenotypes. We find that AL-09 forms fibrils more readily and more rapidly than AL-103 in vitro, mirroring the clinical phenotypes of the patients and suggesting a possible connection between the fibril kinetics of the disease protein and the disease progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21077798      PMCID: PMC3018850          DOI: 10.3109/13506129.2010.530081

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  37 in total

1.  Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates.

Authors:  R Khurana; J R Gillespie; A Talapatra; L J Minert; C Ionescu-Zanetti; I Millett; A L Fink
Journal:  Biochemistry       Date:  2001-03-27       Impact factor: 3.162

Review 2.  Amyloidosis.

Authors:  M A Gertz; M Q Lacy; A Dispenzieri
Journal:  Hematol Oncol Clin North Am       Date:  1999-12       Impact factor: 3.722

3.  Monitoring the assembly of Ig light-chain amyloid fibrils by atomic force microscopy.

Authors:  C Ionescu-Zanetti; R Khurana; J R Gillespie; J S Petrick; L C Trabachino; L J Minert; S A Carter; A L Fink
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

Review 4.  Protein folding and misfolding.

Authors:  Christopher M Dobson
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

5.  The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burden.

Authors:  R L Comenzo; Y Zhang; C Martinez; K Osman; G A Herrera
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

6.  A single mutation promotes amyloidogenicity through a highly promiscuous dimer interface.

Authors:  Francis C Peterson; Elizabeth M Baden; Barbara A L Owen; Brian F Volkman; Marina Ramirez-Alvarado
Journal:  Structure       Date:  2010-05-12       Impact factor: 5.006

Review 7.  Protein aggregation and neurodegenerative disease.

Authors:  Christopher A Ross; Michelle A Poirier
Journal:  Nat Med       Date:  2004-07       Impact factor: 53.440

8.  Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL).

Authors:  Roshini S Abraham; Susan M Geyer; Tammy L Price-Troska; Cristine Allmer; Robert A Kyle; Morie A Gertz; Rafael Fonseca
Journal:  Blood       Date:  2002-12-19       Impact factor: 22.113

9.  Solution conditions can promote formation of either amyloid protofilaments or mature fibrils from the HypF N-terminal domain.

Authors:  F Chiti; M Bucciantini; C Capanni; N Taddei; C M Dobson; M Stefani
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

10.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases.

Authors:  Monica Bucciantini; Elisa Giannoni; Fabrizio Chiti; Fabiana Baroni; Lucia Formigli; Jesús Zurdo; Niccolò Taddei; Giampietro Ramponi; Christopher M Dobson; Massimo Stefani
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

View more
  20 in total

1.  Identification of two principal amyloid-driving segments in variable domains of Ig light chains in systemic light-chain amyloidosis.

Authors:  Boris Brumshtein; Shannon R Esswein; Michael R Sawaya; Gregory Rosenberg; Alan T Ly; Meytal Landau; David S Eisenberg
Journal:  J Biol Chem       Date:  2018-10-24       Impact factor: 5.157

2.  Differences in Protein Concentration Dependence for Nucleation and Elongation in Light Chain Amyloid Formation.

Authors:  Luis M Blancas-Mejía; Pinaki Misra; Marina Ramirez-Alvarado
Journal:  Biochemistry       Date:  2017-01-24       Impact factor: 3.162

3.  Tyrosine residues mediate fibril formation in a dynamic light chain dimer interface.

Authors:  Ara Celi DiCostanzo; James R Thompson; Francis C Peterson; Brian F Volkman; Marina Ramirez-Alvarado
Journal:  J Biol Chem       Date:  2012-06-27       Impact factor: 5.157

4.  Recruitment of Light Chains by Homologous and Heterologous Fibrils Shows Distinctive Kinetic and Conformational Specificity.

Authors:  Luis M Blancas-Mejía; Marina Ramirez-Alvarado
Journal:  Biochemistry       Date:  2016-05-16       Impact factor: 3.162

Review 5.  Current perspectives on cardiac amyloidosis.

Authors:  Jian Guan; Shikha Mishra; Rodney H Falk; Ronglih Liao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

6.  Glycosaminoglycans promote fibril formation by amyloidogenic immunoglobulin light chains through a transient interaction.

Authors:  Douglas J Martin; Marina Ramirez-Alvarado
Journal:  Biophys Chem       Date:  2011-05-18       Impact factor: 2.352

Review 7.  Systemic amyloidoses.

Authors:  Luis M Blancas-Mejía; Marina Ramirez-Alvarado
Journal:  Annu Rev Biochem       Date:  2013-02-28       Impact factor: 23.643

8.  Cell Damage in Light Chain Amyloidosis: FIBRIL INTERNALIZATION, TOXICITY AND CELL-MEDIATED SEEDING.

Authors:  Marta Marin-Argany; Yi Lin; Pinaki Misra; Angela Williams; Jonathan S Wall; Kyle G Howell; Laura R Elsbernd; Megan McClure; Marina Ramirez-Alvarado
Journal:  J Biol Chem       Date:  2016-07-26       Impact factor: 5.157

Review 9.  Amyloid formation in light chain amyloidosis.

Authors:  Marina Ramirez-Alvarado
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

10.  Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.

Authors:  Pamina Kazman; Marie-Theres Vielberg; María Daniela Pulido Cendales; Lioba Hunziger; Benedikt Weber; Ute Hegenbart; Martin Zacharias; Rolf Köhler; Stefan Schönland; Michael Groll; Johannes Buchner
Journal:  Elife       Date:  2020-03-10       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.